By combining primary T-cell culture and a syngeneic mouse tumor model with both genome-wide and custom CRISPR/Cas9 screenings, we systematically identified genes and pathways that regulate PD-1 expression and functions of CD8<sup>+</sup> T-cells. The gene discussed is CD8A; the disease is neoplasm.